Regulation of the vasculature: Clues from lupus

Current Opinion in Rheumatology

Volumn 14, Issue 5, 2002, Pages 504-509

  Merrill, Joan T ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PRASTERONE; PROGESTERONE; SEX HORMONE; AUTACOID;

ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; B LYMPHOCYTE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HUMAN; HUMAN CELL; INFLAMMATION; LIPID METABOLISM; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ARTERIOSCLEROSIS; BLOOD VESSEL; FEMALE; HOMEOSTASIS; IMMUNOLOGY; MALE; PATHOLOGY; PATHOPHYSIOLOGY;

ARTERIOSCLEROSIS; BLOOD VESSELS; FEMALE; HOMEOSTASIS; HUMAN; INFLAMMATION MEDIATORS; LIPIDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; HUMANS; LIPID METABOLISM;

EID: 0036707729     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200209000-00004     Document Type: Review

References (60)

1. Effect of myosin light chain kinase, protein kinase A, and protein kinase C inhibition on porcine oocyte activation
2. Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation
3. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells
4. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway
5. cAMP-dependent and -independent downregulation of type II Na-Pi cotransporters by PTH
6. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways
7. Interleukin-8: An autocrine inflammatory mediator
8. Studies and perspectives of protein kinase C
9. Protein kinases A and C are opponents in modulating glial Ca2+-activated K+ channels
10. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways
11. C-reactive protein and atherothrombosis
12. Inflammatory mechanisms in atherosclerosis: From laboratory evidence to clinical application
13. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium
14. CD40 co-stimulatory molecule expression by dendritic cells in primary atherosclerotic lesions in carotid arteries and in stenotic saphenous vein coronary artery grafts
15. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques
16. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: Effects of expanded-dose simvastatin
17. Generation of C-reactive protein and complement components in atherosclerotic plaques
18. Complement activation in hypercholesterolemia
19. Complement activation in heart diseases. Role of oxidants
20. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients
21. Predominance of Th1 immune response in diffuse proliferative lupus nephritis
22. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus
23. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus
24. Angiogenesis and macrophage activation in endometriosis
25. Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids
26. Hormone replacement therapy, inflammation, and hemostasis in elderly women
27. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus
28. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
29. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women
30. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease
31. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis
32. Stress and the menstrual cycle: Relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey
33. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells
34. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL Ipr/Ipr mice
35. Reproductive condition and the low-dose endotoxin-induced inflammatory response in rats: Glomerular influx of inflammatory cells and expression of adhesion molecules
36. Estrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor
37. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and Fas expression
38. Estrogen and progesterone inhibit vascular smooth muscle proliferation
39. Regulation of the immune response by sex hormones: I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation
40. 17beta-estradiol inhibits apoptosis of endothelial cells
41. Effects of 17beta-estradiol and progesterone on interleukin-6 production and proliferation of human umbilical vein endothelial cells
42. Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression
43. Parturition: Steroids, prostaglandin E2, and expression of adhesion molecules by endothelial cells
44. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease
45. The effects of sex hormones on the immune system in pregnancy
46. Low plasma androgens in women with systemic lupus erythematosus
47. Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus
48. Hormones, pregnancy, and autoimmune diseases
49. The beneficial effects of treatment with tamoxifen and anti-estradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations
50. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
51. Gender differences in autoimmune diseases: Estrogen increases calcineurin expression in systemic lupus erythematosus
52. Isolation and characterization of an estrogen binding protein which may integrate the plethora of estrogenic actions in non-reproductive organs
53. Emerging concepts of the molecular basis for estrogen effects on T lymphocytes in systemic lupus erythematosus
54. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus
55. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus
56. Hormone replacement therapy in systemic lupus erythematosus
57. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE)
58. Oral contraceptives in women with systemic lupus erythematosus
59. Differential response in cell proliferation to beta estradiol in coronary arterial vascular smooth muscle cells obtained from mature female versus male animals
60. Relaxant effects of 17 beta-estradiol in the rat tail artery are greater in females than males